Associations of Endogenous Hormones With HDL Novel Metrics Across the Menopause Transition: The SWAN HDL Study
- PMID: 34390340
- PMCID: PMC8684446
- DOI: 10.1210/clinem/dgab595
Associations of Endogenous Hormones With HDL Novel Metrics Across the Menopause Transition: The SWAN HDL Study
Abstract
Context: Novel metrics of high-density lipoprotein (HDL) (subclasses, lipid content, and function) may improve characterization of the anti-atherogenic features of HDL. In midlife women, changes in these metrics vary by time relative to the final menstrual period (FMP), supporting a contribution of estradiol (E2) and follicle-stimulating hormone (FSH).
Objective: We tested associations of endogenous E2 and FSH with novel HDL metrics and assessed whether these associations varied by time relative to FMP.
Methods: This study was a longitudinal analysis from the Study of Women's Health Across the Nation (SWAN) HDL study, using a community-based cohort of 463 women, baseline mean age 50.2 (2.7) years. The main outcome measures were HDL cholesterol efflux capacity (HDL-CEC), HDL phospholipids (HDL-PL), HDL triglycerides (HDL-Tg), HDL particles (HDL-P), HDL size, and HDL cholesterol (HDL-C).
Results: In multivariable analyses, E2 was positively associated with HDL size, large HDL-P, HDL-CEC, and HDL-Tg, but negatively with medium HDL-P (P values < 0.05). The positive association between E2 and HDL-Tg was stronger 2 years post-FMP than before, (interaction P = 0.031). FSH was positively related to total and medium HDL-P, but negatively to HDL size, large HDL-P, and HDL-CEC per particle (P values < 0.05). Associations of higher FSH with greater total HDL-P and smaller HDL size were only evident at/after menopause (interaction P values < 0.05).
Conclusion: Some of the associations linking E2 and FSH with novel HDL metrics were vulnerable to time relative to menopause onset. Whether a late initiation of hormone therapy relative to menopause could have a detrimental effect on lipid content of HDL particles should be tested in the future.
Keywords: climacteric; follicle-stimulating hormone; high-density lipoprotein; sex hormones; subclasses.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures
Comment in
-
Estradiol and HDL Function in Women - A Partnership for Life.J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2192-e2194. doi: 10.1210/clinem/dgab811. J Clin Endocrinol Metab. 2022. PMID: 34788853 Free PMC article. No abstract available.
References
-
- Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 1986;256(20):2835-2838. - PubMed
-
- Sharrett AR, Ballantyne CM, Coady SA, et al. ; Atherosclerosis Risk in Communities Study Group . Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 2001;104(10):1108-1113. - PubMed
-
- Barter PJ, Caulfield M, Eriksson M, et al. ; ILLUMINATE Investigators . Effects of torcetrapib in patients at high risk for coronary events. n Engl j Med. 2007;357(21):2109-2122. - PubMed
-
- Nissen SE, Tardif JC, Nicholls SJ, et al. ; ILLUSTRATE Investigators . Effect of torcetrapib on the progression of coronary atherosclerosis. n Engl j Med. 2007;356(13):1304-1316. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AG012495/AG/NIA NIH HHS/United States
- R01 AG062622/AG/NIA NIH HHS/United States
- R01 AG058690/AG/NIA NIH HHS/United States
- U01 AG012539/AG/NIA NIH HHS/United States
- U01 AG012554/AG/NIA NIH HHS/United States
- U01 AG012505/AG/NIA NIH HHS/United States
- U01 AG012546/AG/NIA NIH HHS/United States
- U01 AG012535/AG/NIA NIH HHS/United States
- U19 AG063720/AG/NIA NIH HHS/United States
- U01 AG017719/AG/NIA NIH HHS/United States
- U01 NR004061/NR/NINR NIH HHS/United States
- U01NR004061/NH/NIH HHS/United States
- NR/NINR NIH HHS/United States
- U01 AG012553/AG/NIA NIH HHS/United States
- AG058690/AG/NIA NIH HHS/United States
- U01 AG012531/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
